Translational and Therapeutic Evaluation of RAS-GTP Inhibition by RMC-6236 in RAS-Driven Cancers
Jingjing Jiang(Revolution Medicines (United States)), Mallika Singh(Revolution Medicines (United States))
Cited by 267
Related Papers
High-throughput screening using patient-derived tumor xenografts to predict clinical trial drug response
|Nature Medicine|2015|1.4k
Proapoptotic Activation of Death Receptor 5 on Tumor Endothelial Cells Disrupts the Vasculature and Reduces Tumor Growth
|Cancer Cell|2012|61
A neomorphic protein interface catalyzes covalent inhibition of RAS <sup>G12D</sup> aspartic acid in tumors
|Science|2025|31
Tumor-selective effects of active RAS inhibition in pancreatic ductal adenocarcinoma
|bioRxiv (Cold Spring Harbor Laboratory)|2023|11